Skip to main content
. 2017 Feb 3;17:98. doi: 10.1186/s12885-017-3088-9

Table 4.

Outcome measures, instruments, modes of administration, and time points of the study

Measures Instruments Time point Mode of administration
t 0 (baseline) t 1 (12 weeks) t 2 (24 weeks) Online survey RA data collection
Background information
Socio-demographics
Medical and surgical history X Assesses changes in medical/surgical history, and medications since baseline X
Cancer diagnosis and treatment X X
Medications X X
Subjective health indicators
HRQoL FACT G [18] X X X X
SF – 36 [41] X X X X
Depression CES – D [42]
Anxiety Zung SAS [43]
Sexuality
Sexual function FSFI [44] X X X X
Exercise self-efficacy ESE [45] X X X X
Dietary self-efficacy DSE [45] X X X X
Menopausal symptoms
Menopausal symptoms GCS [23] X X X X
Modifiable lifestyle factors
Diet FFQ [46, 47] X X X X
Physical Activity IPAQ [48]
Sleep PSQI [27]
Waist and hip circumference X X X X
Cost effectiveness evaluation
Calendar of costs incurred X X X X

FACT G Functional Assessment of Cancer Therapy – General, SF – 36, Short Form 36, CES – D, Center for Epidemiologic Studies Depression Scale, Zung SAS Zung self-rating anxiety scale, FSFI Female Sexual Function Index, ESE Exercise Self-Efficacy, DSE Dietary Self-Efficacy, GCS Greene Climacteric Scale; FFQ Food Frequency Questionnaire, IPAQ International Physical Activity Questionnaire, PSQI Pittsburgh sleep quality index